Figure 1From: Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab Kaplan-Meier progression-free survival by LCS6 wild-type ( N = 451) and LCS6 variant ( N = 84), log rank P = 0.16. Back to article page